Oocyte donation programs: Strategy for improving results

Annals of the New York Academy of Sciences

Volumn 1221, Issue 1, 2011, Pages 27-31

  Borini, Andrea ^a   Suriano, Rosanna ^a   Barberi, Marzia ^a   Dal Prato, Luca ^a   Bulletti, Carlo ^b  

^a Tecnobios Procreazione   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cryobank; Embyro implantation; Oocyte; Oocyte donation

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ESTRADIOL VALERATE; GONADORELIN AGONIST; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ARTICLE; CELL SYNCHRONIZATION; CRYOPRESERVATION; DISEASE TRANSMISSION; DRUG HALF LIFE; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FREEZE THAWING; HIGH RISK PATIENT; HORMONAL THERAPY; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; MATERNAL AGE; OOCYTE DONATION; OOCYTE MATURATION; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PATIENT SAFETY; PREGNANCY OUTCOME; PREGNANCY RATE; RECIPIENT;

EID: 79952687800     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05934.x     Document Type: Article

References (43)

1. Bustillo, M. et al 1984. Non surgical ovum transfer as a treatment in infertile women. Preliminary experience. J. Am. Med. Assoc. 251: 1171-1173.
2. Budak, E. et al 2007. Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnancies. Fertil. Steril. 88: 342-349.
3. Noyes, N. et al 2001. Factors useful in predicting the success of oocyte donation: a 3-year retrospective study. Fertil. Steril. 76: 92-97.
4. Garcia-Velasco, J.A. et al 2003. Factors that determine discordant outcome from shared oocytes. Fertil. Steril. 80: 54-60.
5. Remohi, J. et al 1997. Pregnancy and birth rates after oocyte donation. Fertil. Steril. 67: 717-23.
6. Moomjy, M. et al 1999. Oocyte donation: insights into implantation. Fertil. Steril. 71: 15-21.
7. Soares, S.R. et al 2008, Clinical factors affecting endometrial receptiveness in oocyte donation cycles. Fertil. Steril. 89: 491-501.
8. Borini, A. et al 1996. Oocyte donation program: pregnancy and implantation rates in women of different ages sharing oocytes from single donor. Fertil. Steril. 65: 94-97.
9. Simon, C. et al 2003. The role of estrogen in uterine receptivity and blastocyst implantation. Trends Endocrinol. Metab. 14: 197-199.
10. Younis, J.S. et al 1996. Endometrial preparation: lessons from oocyte donation. Fertil. Steril. 66: 873-884.
11. Devroey, P. et al 1998. Preparation of endometrium for egg donation. Hum. Reprod. Update 4: 856-861.
12. Garci{dotless}a-Velasco, J.A. et al 2001. Endometrial receptivity in terms of pinopode expression is not impaired in women with endometriosis in artificially prepared cycles. Fertil. Steril. 75: 1231-1233.
13. Obornà, I. et al 2004. Changes in the development of uterine pinopodes in steroid hormone supplemented cycles. Physiol. Res. 53: 423-429.
14. Thong, K.J. et al 2003. The administration of the GnRH antagonist centrorelix to oocyte donors simplifi es oocyte donation. Hum. Reprod. 18: 1256-1258.
15. Saucedo de la Llata, E. et al. (2004. Comparison of GnRH agonists and antagonists in an ovular donation program. Ginecol. Obstet. Mexico 72: 53-56.
16. Yaron, Y. et al 1995. Uterine preparation with estrogen for oocyte donation: assessing the effect of treatment duration on pregnancy rates. Fertil. Steril. 63: 1284-1286.
17. Remohi, J. et al 1995. Long oestradiol replacement in an oocyte donation program. Hum. Reprod. 10: 1387-1391.
18. Borini, A. et al 2001. Effect of duration of estradiol replacement on the outcome of oocyte donation. J. Ass. Reprod. Gen. 18: 185-190.
19. Wada, I. et al 1993. Assisted conception using buserelin and human menopausal gonadotrophins in women with polycystic ovary syndrome. Br. J. Obstet. Gynaecol. 100: 365-369.
20. MacDougall, M.J. et al 1992. In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum. Reprod. 7: 597-600.
21. Tummon, I. et al 2005. Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review. Acta. Obstet. Gynecol. Scand. 84: 611-616.
22. Engmann, L. et al 1999. The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. Hum. Reprod. 14: 167-171.
23. Engmann, L. et al 2008. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil. Steril. 89: 84-91.
24. Griesinger, G. et al 2006. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum. Reprod. Update 12: 159-168.
25. Melo, M. et al 2009. GnRH agonist versus recombinant HCG in an oocyte donation program: a randomized, prospective, controlled, assessor-blind study. Reprod. Biomed. Online 19: 486-492.
26. 2008. Guidelines for gamete and embryo donation: a Practice Committee report. Practice Committee of the American Society for Reproductive Medicine, and the Practice Committee of the Society for Assisted Reproductive Technology.
27. Borini, A. et al 1998. Pregnancies after oocyte freezing and thawing: preliminary data. Hum.Reprod. 13(Suppl. 1): 124-125.
28. Porcu, E. et al 2000. Clinical experience and applications of oocyte cryopreservation. Mol. Cell. Endocrinol. 169: 33-37.
29. Borini, A. et al 2008. Clinical efficiency of oocyte and embryo cryopreservation. Ann. N.Y. Acad. Sci. 1127: 49-58.
30. Cobo, A. et al 2008. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the cryotop method. Fertil. Steril. 89: 1657-1664.
31. Nagy, Z.P. et al 2009. Clinical evaluation of the efficiency of an oocyte donation program using egg cryo-banking. Fertil. Steril. 92: 520-526.
32. Rienzi, L. et al 2010. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum. Reprod. 25: 66-73.
33. Fabbri, R. et al 2001. Human oocyte cryopreservation: new perspectives regarding oocyte survival. Hum. Reprod. 16, 411-416.
34. Boldt, J. et al 2006. Human oocyte cryopreservation: 5-year experience with a sodium-depleted slow freezing method. Reprod. Biomed. Online. 13: 96-100.
35. Borini, A. et al 2006. Cumulative pregnancy rates resulting from the use of fresh and frozen oocytes: 7 years' experience. Reprod. Biomed. Online 12: 481-486.
36. Levi Setti, P.E. et al 2006. Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum. Reprod. 21: 370-375.
37. De Santis, L. et al 2007. Oocyte cryopreservation: clinical outcome of slow-cooling protocols differing in sucrose concentration. Reprod. Biomed. Online 14: 57-63.
38. Corte Costituzionale. 2009. Sentenza 151/09 nei giudizi di legittimita' costituzionale dell'articolo 6, comma 3, e dell'articolo 14, commi 1, 2, 3 e 4, della legge 19 febbraio 2004, n. 40 (Norme in materia di procreazione medicalmente assistita).
39. Borini, A. et al 2007. Evidence-based clinical outcome of oocyte slow cooling. Reprod. Biomed. Online 15: 175-181.
40. Kuwayama, M. et al 2005 Highly efficient vitrification method for cryopreservation of human oocytes. Reprod. Biomed. Online 11: 300-308.
41. Bianchi, V. et al 2007. Differential sucrose concentration during dehydration (0.2 mol/l) and rehydration (0.3 mol/l) increases the implantation rate of frozen human oocytes. Reprod. Biomed. Online 14: 64-71.
42. Chian, R.C. et al 2008. Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Reprod. Biomed. Online 16: 608-610.
43. Sauer, M.V. et al 2005. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Reprod. Biomed. Online 12: 153-162.